Donald J. D’Amico, MD, presents 1-year pivotal results comparing a Wnt pathway agonist with ranibizumab in diabetic macular edema.
Donald J. D'Amico, MD
Advertisement
Donald J. D’Amico, MD, is with Weill Cornell Medicine and New York-Presbyterian Hospital.
Articles by Donald J. D'Amico, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
AAO 2026: DAYBREAK shows tarcocimab and tabirafusp-ted noninferior to aflibercept in wet AMD
2
AAO 2026: Optogenetic gene therapy heads to phase 2 trial in geographic atrophy
3
Slowing Stargardt: What a 36% reduction in lesion growth could mean for adolescent patients
4
AAO 2026: Blood pressure and optic nerve perfusion: a complex relationship
5